[go: up one dir, main page]

GB2456528B - Antioxidant for use in cosmetic, medicated and pharmaceutical compositions - Google Patents

Antioxidant for use in cosmetic, medicated and pharmaceutical compositions

Info

Publication number
GB2456528B
GB2456528B GB0800749.4A GB0800749A GB2456528B GB 2456528 B GB2456528 B GB 2456528B GB 0800749 A GB0800749 A GB 0800749A GB 2456528 B GB2456528 B GB 2456528B
Authority
GB
United Kingdom
Prior art keywords
medicated
cosmetic
antioxidant
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB0800749.4A
Other versions
GB2456528A (en
GB0800749D0 (en
Inventor
Elliot Isaacs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pangaea Laboratories Ltd
Original Assignee
Pangaea Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangaea Laboratories Ltd filed Critical Pangaea Laboratories Ltd
Priority to GB0800749.4A priority Critical patent/GB2456528B/en
Publication of GB0800749D0 publication Critical patent/GB0800749D0/en
Publication of GB2456528A publication Critical patent/GB2456528A/en
Application granted granted Critical
Publication of GB2456528B publication Critical patent/GB2456528B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0800749.4A 2008-01-16 2008-01-16 Antioxidant for use in cosmetic, medicated and pharmaceutical compositions Active GB2456528B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0800749.4A GB2456528B (en) 2008-01-16 2008-01-16 Antioxidant for use in cosmetic, medicated and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0800749.4A GB2456528B (en) 2008-01-16 2008-01-16 Antioxidant for use in cosmetic, medicated and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB0800749D0 GB0800749D0 (en) 2008-02-20
GB2456528A GB2456528A (en) 2009-07-22
GB2456528B true GB2456528B (en) 2012-08-22

Family

ID=39145001

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0800749.4A Active GB2456528B (en) 2008-01-16 2008-01-16 Antioxidant for use in cosmetic, medicated and pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB2456528B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4469C1 (en) * 2016-11-03 2017-10-31 Государственный Университет Молд0 Use of di(µ-S)-bis{(4-aminobenzenesulphamide)-chloro-[2-picolidene-4-phenylthiosemicarbazidato-(1-)]-copper(II)} as an antioxidant

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046056T2 (en) 2015-04-09 2020-01-28 Laboratori Baldacci Spa Pyrrolidone carboxylic acid (pca) for ophthalmic use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271674B (en) * 1994-07-15 1997-06-04 Angelica S P A Istituto Erbori Composition for cosmetic use including oligoelements
WO2001028552A2 (en) * 1999-10-19 2001-04-26 The Procter & Gamble Company Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts
WO2004010958A2 (en) * 2002-07-31 2004-02-05 Shaklee Corporation A method for maximizing scalp health and inducing enhanced visual and tactile hair quality
WO2004041174A2 (en) * 2002-10-31 2004-05-21 Johnson & Johnson Consumer Companies,Inc. Compositions for darkening the skin and/or hair
WO2005082386A2 (en) * 2004-02-20 2005-09-09 Human Matrix Sciences, Llc Manganese and iron based compounds for elastogenesis and connective tissue treatment
US20050239764A1 (en) * 2004-04-23 2005-10-27 Ajinomoto Co., Inc. Zinc pyrrolidonecarboxylate dihydrate and method of producing the same
US20050271606A1 (en) * 2004-06-08 2005-12-08 Keiji Iwasaki Composition for treating inflammation which contains zinc pyrrolidonecarboxylate

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271674B (en) * 1994-07-15 1997-06-04 Angelica S P A Istituto Erbori Composition for cosmetic use including oligoelements
WO2001028552A2 (en) * 1999-10-19 2001-04-26 The Procter & Gamble Company Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts
WO2004010958A2 (en) * 2002-07-31 2004-02-05 Shaklee Corporation A method for maximizing scalp health and inducing enhanced visual and tactile hair quality
WO2004041174A2 (en) * 2002-10-31 2004-05-21 Johnson & Johnson Consumer Companies,Inc. Compositions for darkening the skin and/or hair
WO2005082386A2 (en) * 2004-02-20 2005-09-09 Human Matrix Sciences, Llc Manganese and iron based compounds for elastogenesis and connective tissue treatment
US20050239764A1 (en) * 2004-04-23 2005-10-27 Ajinomoto Co., Inc. Zinc pyrrolidonecarboxylate dihydrate and method of producing the same
US20050271606A1 (en) * 2004-06-08 2005-12-08 Keiji Iwasaki Composition for treating inflammation which contains zinc pyrrolidonecarboxylate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
English language EPODOC abstract for patent number IT 1271674 B (ANGELICA S P A ISTITUTO ERBORI). *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4469C1 (en) * 2016-11-03 2017-10-31 Государственный Университет Молд0 Use of di(µ-S)-bis{(4-aminobenzenesulphamide)-chloro-[2-picolidene-4-phenylthiosemicarbazidato-(1-)]-copper(II)} as an antioxidant

Also Published As

Publication number Publication date
GB2456528A (en) 2009-07-22
GB0800749D0 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL271132A (en) Novel dosage and formulation
PL3075401T3 (en) Preservation for cosmetic, toiletry and pharmaceutical compositions
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL206952A (en) Aminodihydrothiazine derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
ZA201003899B (en) Novel dosage and formulation
ZA201006941B (en) Compositions and methods for skin care
IL234166B (en) Isoindoline compounds, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments
EP2441453A4 (en) Pharmaceutical composition for use in medical and veterinary ophthalmology
IL212960A (en) Sulfonamide derivatives, compositions comprising same and use thereof in treatment of cancer
IL218169A (en) Quinazoline compounds and pharmaceutical compositions comprising same for use in therapy
IL207569A0 (en) Compositions and methods for drug delivery
HK1146220A1 (en) Gel technology suitable for use in cosmetic compositions
IL213019A (en) 1-aza-3-heteroaryl-azulene derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
IL195764A0 (en) Compositions and methods for drug delivery
EP2241569A4 (en) Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
EP2261221A4 (en) Epothilone analogues, their pharmaceutical compositions, their use and their preparations
GB2479251B (en) Cosmetic or pharmaceutical composition, in particular intended for care or for makeup
IL207205A0 (en) Triazolopyridazines as par1 inhibitors, their preparation and use as medicaments
GB2456528B (en) Antioxidant for use in cosmetic, medicated and pharmaceutical compositions
HK1155062A1 (en) Pharmaceutical composition and combined agent
IL206936A0 (en) 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same